Duchenne muscular dystrophy is a genetic disorder that causes severe muscle degeneration over time. Symptoms for Duchenne muscular dystrophy are usually noticed in males in early childhood between the ages of three and five and progress rapidly. Duchenne muscular dystrophy is caused by a damaged gene on the X chromosome, which prevents the body from making the protein dystrophin. Dystrophin aids in maintaining the structure of muscle cells, so without it, muscles weaken. There is no cure for Duchenne muscular dystrophy, but with cardiac and respiratory care along with physical and occupational therapy, individuals with the disorder are living longer.
Muscular Dystrophy, Duchenne Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Muscular Dystrophy, Duchenne below!
For more information on how to use Laverne, please read the How to Guide.
We have 1093 products for the study of Muscular Dystrophy, Duchenne that can be applied to Chromatin Immunoprecipitation, Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Muscular Dystrophy, Duchenne is also known as Benign Duchenne Muscular Dystrophy, Duchenne Muscular Dystrophy, Duchenne Type Progressive Muscular Dystrophy, Duchenne-type Progressive Muscular Dystrophy, Dystrophy, Duchenne Muscular.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.